Clinical Trials by Tom Brody, Hardcover, 9780128042175 | Buy online at The Nile
Departments
 Free Returns*

Clinical Trials

Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines

Author: Tom Brody  

A hands-on guidebook that integrates the most practical aspects of clinical trial design with important content on laboratory studies of human data, patient safety, regulatory requirements and much more

Read more
Product Unavailable

PRODUCT INFORMATION

Summary

A hands-on guidebook that integrates the most practical aspects of clinical trial design with important content on laboratory studies of human data, patient safety, regulatory requirements and much more

Read more

Description

Clinical Trials, Second Edition, offers those engaged in clinical trial design a valuable and practical guide. This book takes an integrated approach to incorporate biomedical science, laboratory data of human study, endpoint specification, legal and regulatory aspects and much more with the fundamentals of clinical trial design. It provides an overview of the design options along with the specific details of trial design and offers guidance on how to make appropriate choices. Full of numerous examples and now containing actual decisions from FDA reviewers to better inform trial design, the 2nd edition of Clinical Trials is a must-have resource for early and mid-career researchers and clinicians who design and conduct clinical trials.

Read more

About the Author

Dr. Tom Brody received his PhD from the University of California at Berkeley in 1980, and conducted postdoctoral research at University of Wisconsin-Madison and also at U.C. Berkeley. His 20 research publications concern the metabolism and pharmacology of folates, cloning an anti-cancer gene (XPE gene), and the structure of an antibody (natalizumab) used for treating multiple sclerosis. The author has 15 years of pharmaceutical industry experience, acquired at Schering-Plough, Cerus Corporation, and Elan Pharmaceuticals, and has contributed to FDA submissions for the indications of multiple sclerosis, melanoma, head and neck cancer, liver cancer, pancreatic cancer, and hepatitis C. At an earlier time, he wrote two editions of Clinical Trials, published by Elsevier, Inc. The author has 16 years of training and experience in the Code of Federal regulations, as it applies to pharmaceuticals and clinical trial design.

Read more

Product Details

Publisher
Elsevier Science Publishing Co Inc | Academic Press Inc
Published
12th March 2016
Edition
2nd
Pages
896
ISBN
9780128042175

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.

Product Unavailable